2016
DOI: 10.1007/s11538-016-0177-x
|View full text |Cite
|
Sign up to set email alerts
|

Mathematical Modeling of the Role of Survivin on Dedifferentiation and Radioresistance in Cancer

Abstract: We use a mathematical model to investigate cancer resistance to radiation, based on dedifferentiation of non-stem cancer cells into cancer stem cells. Experimental studies by Iwasa 2008, using human non-small cell lung cancer (NSCLC) cell lines in mice, have implicated the inhibitor of apoptosis protein survivin in cancer resistance to radiation. A marked increase in radio-sensitivity was observed, after inhibiting survivin expression with a specific survivin inhibitor YM155 (sepantronium bromide). It was sugg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
10
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 51 publications
1
10
0
Order By: Relevance
“…The survivin effect is then controlled by administration of YM155. In (Rhodes and Hillen 2016) a mathematical model was developed to investigate the combination of YM155 administration and radiation therapy on the CSC dynamics.…”
Section: Introductionmentioning
confidence: 99%
“…The survivin effect is then controlled by administration of YM155. In (Rhodes and Hillen 2016) a mathematical model was developed to investigate the combination of YM155 administration and radiation therapy on the CSC dynamics.…”
Section: Introductionmentioning
confidence: 99%
“…This is confirmed by preliminary simulations that combine a spatial extension of the model in ref. 46, which accounts for the reprogrammingpromoter survivin and its inhibitor YM155, with the multispecies model presented here (results not shown). A complete study will be presented in future work.…”
Section: Discussionmentioning
confidence: 98%
“…When combined with AM therapies (chemo-and radio-), these combinatorial treatments can eradicate the tumor by the time treatment has ended. When reprogramming of GBM-differentiated cells into GSCs is considered, anti-reprogramming therapies might also be required in the combinatorial treatments to eradicate the tumor (46). However, if the reprogramming rates are sufficiently small, our proposed combination strategy should still be effective.…”
Section: Discussionmentioning
confidence: 99%
“…It is expressed in ~60 different human tumor types, with the highest levels of expression observed in breast and lung cancer cell lines (47)(48)(49). The survivin protein inhibits caspase activation, thereby leading to negative regulation of apoptosis.…”
Section: Discussionmentioning
confidence: 99%